Contact Us
June 14–18, 2026

DIA 2026 Global Annual Meeting

Philadelphia, PA
UBC is proud to attend the DIA 2026 Global Annual Meeting, the premier life sciences conference convening thousands of drug development professionals from across industry, regulatory agencies, and academia. This flagship event is where the global life sciences community comes together to address the most pressing challenges in drug development, safety, and patient access, making it an ideal forum to explore the future of pharmacovigilance and risk management for specialty therapies.

UBC partners with biopharma to deliver sophisticated, tech-enabled safety and risk management programs that protect patients and support regulatory compliance throughout the product lifecycle. Our team brings decades of pharmacovigilance expertise to every program, combining deep regulatory knowledge with purpose-built technology to help sponsors maintain confidence and control.

  • Pharmacovigilance: Global safety surveillance, signal detection, case processing, and regulatory reporting designed to meet evolving agency expectations.
  • Safety & Risk Management: Comprehensive drug safety solutions, including REMS program design and implementation, risk minimization strategies, and integrated benefit/risk assessment.
  • Regulatory Expertise: Proven experience supporting FDA, EMA, and global agency interactions to keep your program compliant and inspection-ready.
  • Specialty Therapy Focus: Tailored strategies built for the complexity of oncology, rare disease, cell therapy, and gene therapy programs.

Connect with UBC at DIA 2026 to learn how our pharmacovigilance and risk management solutions can safeguard your program and support better patient outcomes.
UBC Pinwheel logo

Schedule a Meeting

To use these forms you must accept all cookies

Learn More About UBC

We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.

Get in Touch

Other Events

View more
A city view of the Philadelphia downtown skyline.
Trade show
December 10, 2026RSVP

Trade & Channel Strategies 2026

Meet UBC at Trade & Channel Strategies to talk patient access and adherence strategy amid shifting pharmacy and distribution models.
Big Ben, Parliament and Westminster Bridge in London, UK
Trade show
October 21, 2026RSVP

Operationalise: Early Access Programmes Summit Europe 2026

Meet UBC at the Operationalise: Early Access Programmes Summit Europe to talk early access, evidence generation, and safety strategy for global expanded access programs.
New Orleans Downtown Aerial View with River
Trade show
December 15, 2026RSVP

ASH Annual Meeting 2026

Meet UBC at the ASH Annual Meeting, the world's leading hematology conference. Explore evidence generation and risk management solutions for blood disorder programs.

Schedule a Meeting
UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.